Amlaac® (Amla / Indian Gooseberry Extract)

Phyllanthus emblica
Evidence Level
Moderate
1 Clinical Trial
3 Documented Benefits
3/5 Evidence Score

Amlaac® is a standardized extract of amla (Phyllanthus emblica), the Indian gooseberry, one of the most revered fruits in Ayurveda. Exceptionally rich in vitamin C and polyphenols, amla is studied for supporting healthy cholesterol, blood sugar, and antioxidant status.

Studied Dose Commonly around 500 mg to 1 g per day.
Active Compound Standardized amla (Phyllanthus emblica / Emblica officinalis) fruit extract rich in vitamin C, gallic acid, and tannins.

Benefits

Healthy cholesterol

A meta-analysis of randomized trials found amla supported improvements in lipid profile, including total and LDL cholesterol.

Blood-sugar and inflammation support

The same analysis found amla supported healthier glucose and C-reactive protein (an inflammation marker).

Antioxidant defense

Amla is one of nature's richest sources of vitamin C and polyphenols, providing strong antioxidant protection.

Mechanism of action

1

Polyphenol and vitamin C antioxidants

Amla's gallic acid, tannins, and vitamin C scavenge free radicals and support the body's antioxidant systems.

2

Lipid and glucose modulation

Amla polyphenols support healthy cholesterol handling and blood-sugar metabolism.

Clinical trials

1
Amla and Cardiometabolic Markers — Meta-Analysis
PubMed

Systematic review and meta-analysis of randomized trials of amla (Emblica officinalis) on lipid profile, glucose, and C-reactive protein. (Setayesh et al. 2023, Diabetes and Metabolic Syndrome)

Adults across multiple RCTs.

Amla supported improvements in cholesterol, glucose, and inflammation markers versus control.

Side effects and drug interactions

Common Potential side effects

GENERALLY WELL-TOLERATED — adverse effects are uncommon at normal doses.
Mild digestive upset is occasionally reported.
Discontinue if any unusual reaction occurs.

Important Drug interactions

Diabetes medication — amla may lower blood sugar; monitor.
Anticoagulants — possible mild additive effect; monitor.
Tell your doctor if you take cholesterol or diabetes medication.

Frequently asked questions about Amlaac® (Amla / Indian Gooseberry Extract)

What is Amlaac® (Amla / Indian Gooseberry Extract)?

Amlaac® is a standardized extract of amla (Phyllanthus emblica), the Indian gooseberry, one of the most revered fruits in Ayurveda. Exceptionally rich in vitamin C and polyphenols, amla is studied for supporting healthy cholesterol, blood sugar, and antioxidant status.

What is the recommended dosage of Amlaac® (Amla / Indian Gooseberry Extract)?

The clinically studied dose for Amlaac® (Amla / Indian Gooseberry Extract) is Commonly around 500 mg to 1 g per day.. Always follow product labeling and consult a healthcare provider for personalized dosing recommendations.

What is Amlaac® (Amla / Indian Gooseberry Extract) used for?

Amlaac® (Amla / Indian Gooseberry Extract) is studied for healthy cholesterol, blood-sugar and inflammation support, antioxidant defense. A meta-analysis of randomized trials found amla supported improvements in lipid profile, including total and LDL cholesterol.

Are there side effects from taking Amlaac® (Amla / Indian Gooseberry Extract)?

Reported potential side effects may include: GENERALLY WELL-TOLERATED — adverse effects are uncommon at normal doses. Mild digestive upset is occasionally reported. Always consult a healthcare provider before starting any new supplement, especially if you have underlying conditions or take medications.

Is Amlaac® (Amla / Indian Gooseberry Extract) safe to take?

Whether Amlaac® (Amla / Indian Gooseberry Extract) is safe depends on the dose, your overall health, and any medications you take. At studied doses, reported side effects can include: GENERALLY WELL-TOLERATED — adverse effects are uncommon at normal doses. It may also interact with certain medications. Amlaac® (Amla / Indian Gooseberry Extract) is not suitable for everyone — consult a healthcare provider before use if you are pregnant or breastfeeding, have a medical condition, or take prescription medications.

References(1 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Setayesh L, Haghighat N, Rasaei N, et al. The impact of Emblica Officinalis (Amla) on lipid profile, glucose, and C-reactive protein: A systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr. 2023;17(3):102729..PubMedUsed to support: Meta-analysis supporting cardiometabolic benefit of amla.